Nimesulide: Some pharmaceutical and pharmacological aspects - An update

Journal of Pharmacy and Pharmacology

Volumn 52, Issue 5, 2000, Pages 467-486

  Singla, Anil K ^a   Chawla, M ^a   Singh, A ^b  

^a PANJAB UNIVERSITY   (India)

^b Panacea Biotec Ltd   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA CYCLODEXTRIN DERIVATIVE; CARPROFEN; CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DICLOFENAC; DRUG METABOLITE; ETODOLAC; FENTIAZAC; FLOCTAFENINE; FLUFENAMIC ACID; FLURBIPROFEN; HISTAMINE; IBUPROFEN; INDOMETACIN; KETOPROFEN; MEFENAMIC ACID; MELOXICAM; NAPROXEN; NAPROXEN DERIVATIVE; NIMESULIDE; PARACETAMOL; PHENYLBUTAZONE; PIROXICAM; SALICYLATE SODIUM; SULINDAC; TERFENADINE; TOLMETIN; UNINDEXED DRUG;

ALZHEIMER DISEASE; ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIPYRETIC ACTIVITY; ASTHMA; COMPLEMENT INHIBITION; DRUG EFFICACY; DRUG STRUCTURE; DRUG TOLERABILITY; FERTILITY; HISTAMINE RELEASE; HUMAN; KIDNEY FUNCTION; LIVER FUNCTION; MYOMETRIUM; NEUTROPHIL; NONHUMAN; OSTEOARTHRITIS; REVIEW; SKIN FUNCTION; STOMACH FUNCTION;

EID: 0034078135     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357001774255     Document Type: Review

References (150)

1. Andri, L., Senna, G. E., Betteli, C., Givanni, S., Andri, G., Scaricabarozzi, I., Mezzelani, P. (1992) Combined treatment of allergic rhinitis with terfenadine and nimesulide, a nonsteroidal anti-inflammatory drug. Allerg. Immunol. 24: 313-314
2. Andri, L., Senna, G. E., Betteli, C., Givanni, S., Scaricabarozzi, I., Mezzelani, P., Andri, G. (1994) Tolerability of nimesulide in aspirin-sensitive patients. Ann. Allergy 72: 29-32
3. Antonelli, A., Cimino, A., Di Girolamo, A., Filippi, P., Filippin, S., Galetti, G., Marchiori, C., Macucci, L., Mira, E. (1993) The treatment of ENT phlogosis: seaprose-S versus nimesulide. Acta Otorhinolaryngol. Ital. 13 (Suppl): 1-16
4. Asero, R. (1998) Aspirin and paracetamol tolerance in patients with nimesulide induced urticaria. Ann. Allergy Asthma Immunol. 81: 237-238
5. Auteri, A., Saletti, M., Blardi, P., Di Perri, T. (1988) Action of a new non-steroidal anti-inflammatory drug, nimesulide, on activation of the complement system: an in-vitro study. Int. J. Tissue React. 10: 217-221
6. Auteri, A., Bruni, F., Blardi, P., Di Renzo, M., Pasqui, A. L., Saletti, M., Verzuri, M. S., Scaricabarozzi, I., Vargiu, G., Di Perri, T. (1991a) Clinical study on pharmacological interaction between nimesulide and warfarin. Int. J. Clin. Pharmacol. Res. 11: 267-270
7. Auteri, A., Blardi, P., Bruni, F., Domini, L., Pasqui, A. L., Saletti, M., Verzuri, M. S., Scaricabarozzi, I., Vargiu, G., Di Perri, T. (1991b) Pharmacokinetics and pharmacodynamics of slow-release theophylline during treatment with nimesulide. Int. J. Clin. Pharmacol. Res. 11: 211-217
8. Azab, A., Fraifeld, V., Kaplanski, J. (1998) Nimesulide prevents lipopolysaccharide-induced elevation in plasma tumor necrosis factor-alpha in rats. Life Sci. 63: PL 323-327
9. Barbato, F., Cappello, B., La Rotonda, M. I., Miro, A., Morrica, P. (1997) Nimesulide/β-cyclodextrin inclusion compounds: characterization and dissolution studies. Proc. Int. Symp. Control. Rel. Bioact. Mater. 24: 385-386
10. Barberi, I., Macchia, A., Spata, N., Scaricabarozzi, I., Nava, M. L. (1993) Double blind evaluation of nimesulide vs lysine-aspirin in the treatment of paediatric acute respiratory tract infections. Drugs 46 (Suppl. 1): 219-221
11. Beguma-Nibasheka, M., Nathanielsz, P. W. (1998) In-vivo administration of nimesulide, a selective PGHS-2 inhibitor, increases in-vitro myometrial sensitivity to prostaglandins while lowering sensitivity to oxytocin. J. Soc. Gynecol. Investig. 5: 296-299
12. Bernareggi, A. (1993) The pharmacokinetic profile of nimesulide in healthy volunteers. Drugs 46 (Suppl. 1): 64-72
13. Bernareggi, A. (1998) Clinical pharmacokinetics of nimesulide. Clin. Pharmacokinet. 35: 247-274
14. Bernasconi, P., Massera, E. (1985) Evaluation of a new pharmaceutical form of nimesulide for the treatment of influenza. Drugs Exp. Clin. Res. 11: 739-743
15. Berti, F., Rossoni, G., Buschi, A., Robuschi, M., Villa, L. M. (1990) Antianaphylactic and antihistaminic activity of the nonsteroidal anti-inflammatory compound nimesulide in guinea pig. Arzneim. Forsch. 40: 1011-1016
16. Bevilacqua, M., Vago, T., Baldi, G., Renesto, E., Dallegri, F., Norbiato, G. (1994) Nimesulide decreases superoxide production by inhibiting phosphodiesterase type IV. Eur. J. Pharmacol. 268: 415-423
17. Biscarini, L., Patoia, L., Favero, A. D. (1988) Nimesulide - a new nonsteroidal anti-inflammatory agent. Drugs Today 24: 23-27
18. Bourgeois, P., Dreiser, R. L., Lequesne, M. G., Macciocchi, A., Monti, T. (1994) Multicentre double-blind study to define the most favorable dose of nimesulide in terms of efficacy/safety ratio in the treatment of osteoarthritis. Eur. J. Rheumatol. Inflamm. 14: 39-50
19. Breitner, J. C. (1996) The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease. Annu. Rev. Med. 47: 401-411
20. Capecchi, P. L., Ceccatelli, L., Beermann, U., Pasini, F. L., Di Perri, T. (1993) Inhibition of neutrophil function in-vitro by nimesulide: preliminary evidence of an adenosine-mediated mechanism. Arzneim. Forsch. 43: 992-996
21. Capsoni, F., Venegoni, E., Minonzio, F., Ongari, A. M., Maresca, V., Zanussi, C. (1987) Inhibition of neutrophil oxidative metabolism by nimesulide. Agents Actions 21: 121-129
22. Caputo, R., Gelmetti, C., Grimalt, R., Gianotti, R. (1996) Psoriasiform and sclerodermoid dermatitis of the fingers with apparent shortening of the nail plate: a distinct entity? Br. J. Dermatol. 134: 126-129
23. Carini, M., Aldini, G., Stefani, R., Marinello, C., Facino, R. M. (1998) Mass spectrometric characterization and HPLC determination of the main urinary metabolites of nimesulide in man. J. Pharm. Biomed. Anal. 18: 201-211
24. Cashman, J., McAnulty, G. (1995) Nonsteroidal anti-inflammatory drugs in perisurgical pain management: mechanisms of action and rationale for optimum use. Drugs 49: 51-70
25. Casolaro, V., Meliota, S., Marino, O., Patella, V., de Paulis, A., Guidi, G., Marone, G. (1993) Nimesulide, a sulphonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from basophils and mast cells. J. Pharmacol. Exp. Ther. 267: 1375-1385
26. Castoldi, D., Monzani, V., Tofanetti, O. (1988) Simultaneous determination of nimesulide and hydroxynimesulide in human plasma and urine by high performance liquid chromatography. J. Chromatogr. 425: 413-418
27. Ceserani, R., Casciarri, I., Cavalletti, E., Cazzulani, P. (1991) Action of nimesulide on rat gastric prostaglandins and renal functions. Drug Invest. 3 (Suppl 2): 14-21
28. Chakraborty, I., Das, S. K., Wang, J., Dey, S. K. (1996) Developmental expression of the cyclooxygenase-1 and cyclooxygenase-2 genes in the peri-implantation mouse uterus and their differential regulation by the blastocyst and ovarian steroids. J. Mol. Endocrinol. 16: 107-122
29. Chang, J. W., Coleman, P. D., O'Banion, M. K. (1996) Prostaglandin G/H synthase 2 (cyclooxygenase-2) mRNA expression is decreased in Alzheimer's disease. Neurobiol. Aging 17: 801-808
30. Chang, S. F., Miller, A. M., Ober, R. E. (1977) Determination of an anti-inflammatory methanesulphonanilide in plasma by high speed liquid chromatography. J. Pharm. Sci. 66: 1700-1703
31. Chowdary, K. P. R., Rao, G. D., Babu, I. S. (1997) A new spectrophotometric method for the determination of nimesulide. Indian Drugs 34: 396-398
32. Chowdary, K. P. R., Kumar, K. G., Rao, G. D. (1999) New spectrophotometric methods for the determination of nimesulide. Indian J. Pharm. Sci. 61: 86-89
33. Clive, D. M., Stoff, J. S. (1984) Renal syndromes associated with non steroidal anti-inflammatory drugs. N. Engl. J. Med. 310: 563-572
34. Cook, M. E., Wallen, J. D., Thakur, V. D. (1997) Comparative effects of nabumetone, sulindac and ibuprofen on renal function. J. Rheumatol. 24: 1137-1144
35. Coscarelli, S., Scaricabarozzi, I., Nava, M. L., Alajmo, E. (1993) A comparison of nimesulide and ketoprofen in the prevention and treatment of painful postoperative inflammatory complications of ear, nose and throat surgery. Drugs 46 (Suppl. 1): 174-176
36. Cryer, B., Feldman, M. (1992) Effects of nonsteroidal anti-inflammatory drugs on endogenous gastrointestinal prostaglandins and therapeutic strategies for prevention and treatment of nonsteroidal anti-inflammatory drug induced damage. Arch. Intern. Med. 152: 1145-1155
37. Cunietti, E., Monti, M., Vigano, A., D'Aprile, E., Saligari, A., Scafuro, E., Scaricabarozzi, I. (1993) Nimesulide in the treatment of hyperpyrexia in the aged: double blind comparison with paracetamol. Arzneim. Forsch. 43: 160-162
38. Dallegri, F., Ottonello, L., Dapino, P., Bevilacqua, M. (1992a) The anti-inflammatory drug nimesulide rescues alpha-1-proteinase inhibitor from oxidative inactivation by phagocytosing neutrophils. Respiration 59: 1-4
39. Dallegri, F., Ottonello, L, Dapino, L., Sacchetti, C. (1992b) Effect of nonsteroidal anti-inflammatory drugs on the neutrophil promoted inactivation of alpha-1-proteinase inhibitor. J. Rheumatol. 19: 419-423
40. Dapino, P., Ottonello, L., Dallegri, F. (1994) The anti-inflammatory drug nimesulide inhibits neutrophil adherence to and migration across monolayers of cytokine-activated endothelial cells. Respiration 61: 336-341
41. Davis, R., Brogden, R. N. (1994) Nimesulide: an update of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy. Drugs 48: 431-451
42. De Mello, S. B., Laurindo, I. M., Cossermelli, W. (1994) Action of the 4-nitro-2-phenoxymethane sulfonanilide (nimesulide) on neutrophil chemotaxis and superoxide production. Rev. Paul. Med. 112: 489-494
43. Dionigi, R., Interdonato, P. F., Scaricabarozzi. I. (1992) Evaluation of the efficacy and tolerability of nimesulide in the treatment of mastodynia. Minerva Ginecol. 44: 511-514
44. Eberhart, C. E., Coffey, R. J., Radhika, A., Giardiello, F. M., Ferrenbach, S., DuBois, R. N. (1994) Upregulation of cyclooxygenase-2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 104: 1183-1188
45. Facino, R. M., Carini, M., Aldini, G., Saibene, L., Morelli, R. (1995) Differential inhibition of superoxide, hydroxyl and peroxyl radicals by nimesulide and its main metabolite 4-hydroxy nimesulide. Arzneim. Forsch. 45: 1102-1109
46. Facino, R. M., Carini, M., Aldini, G., Calloni, M. T. (1997) Hydroxynimesulide, the main metabolite of nimesulide, prevents hydroperoxide/hemoglobin-induced hemolysis of rat crythrocytes. Drugs Exp. Clin. Res. 23: 157-165
47. Fallavena, P. R. B., Schapovral, E. E. S. (1995) Spectrophotometric determination of nimesulide in tablets. Rev. Bras. Farm. 76: 30-32
48. Fallavena, P. R. B., Schapovral, E. E. S. (1997) pKa determination of nimesulide in methanol-water mixtures by potentiometric titrations. Int. J. Pharm. 158: 109-112
49. Famaey, J. P. (1997) In-vitro and in-vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide - an overview. Inflamm. Res. 46: 437-446
50. Frazier, L. W., Yorio, T. (1992) Eicosanoids and their functions in renal epithelia ion transport. Proc. Soc. Exp. Biol. Med. 201: 229-243
51. Fusetti, G., Magni, E., Armandola, M. C. (1993) Tolerability of nimesulide: epidemiological data. Drugs 46 (Suppl. 1): 277-280
52. Gandini, R., Montalto, C., Castoldi. D., Monzani, V., Nava, M. L., Scaricabarozzi, I., Vargiu, G., Bartosek, I. (1991) First dose and steady state pharmacokinetics of nimesulide and 4-hydroxy metabolite in healthy volunteers. Farmaco. 46: 1071-1079
53. Giachetti, C., Tenconi, A. (1998) Determination of nimesulide and hydroxynimesulide in human plasma by high performance liquid chromatography. Biomed. Chromatogr. 12: 50-56
54. Gibb, W., Sun, M. (1996) Localization of prostaglandin H synthasc type 2 protein and mRNA in term human foetal membranes and decidua. J. Endocrinol. 150: 497-503
55. Gilroy, D. W., Tomlinson, A., Willoughby, D. A. (1998a) Differential effects of inhibitors of cyclooxygenase (cyclooxygenase-1 and cyclooxygenase-2) in acute inflammation. Eur. J. Pharmacol. 355: 211-217
56. Gilroy, D. W., Tomlinson, A., Greenslade, K., Seed, M. P., Willoughby, D. A. (1998b) The effect of cyclooxygenase-2 inhibitors on cartilage erosion and bone loss in a model of Mycobacterium tuberculosis induced monoarticular arthritis in the rat. Inflammation 22: 509-519
57. Giuseppe, P., Antonino, R., Alessandro, D. B., Donato, Q., Marina, D. F., Donatella, P., Francesca, G., Alberto, V. (1997) Floctafenine: a valid alternative in patients with adverse reactions to nonsteroidal anti-inflammatory drugs. Ann. Allergy Asthma Immunol. 78: 74-78
58. Grant, T. J., Moore, G. G. I., Swingle, K. F. (1975) Anti-inflammatory activity of 4-nitro-2-phenoxymethanesulfonanilide (R 805). Fed. Proc. 34: 759
59. Gretzer, B., Ehrlich, K., Maricic, N., Lambrecht, N., Respondek, M., Peskar, B. M. (1998) Selective cyclooxygenase-2 inhibitors and their influence on the protective effect of a mild irritant in the rat stomach. Br. J. Pharmacol. 123: 927-935
60. Gustafson-Svard, C., Lilja, I., Hallbook, O., Sjodahl, R. (1996) Cyclooxygenase-1 and cyclooxygenase-2 gene expression in human colorectal adenocarcinomas and in azoxymethane induced colonie tumours in rats. Gut 38: 79-84
61. Hampel, H., Muller, N. (1995) Inflammatory and immunological mechanisms in Alzheimer's disease. Drug News Prespect. 8: 599-608
62. Harada, Y., Kawamura, M., Hatanaka, K., Saito, M., Ogino, M., Ohno, T., Ogino, K., Yang, Q. (1998) Differing profiles of prostaglandin formation inhibition between selective prostaglandin H synthase-2 inhibitors and conventional NSAIDs in inflammatory and non-inflammatory sites of the rat. Prostaglandins Other Lipid Mediat. 55: 345-358
63. Hawkey, C. J. (1999) COX-2 inhibitors. Lancet 353: 307-314
64. Hirata, T., Ukawa, H., Kitamura, M., Takeuchi, K. (1997) Effects of selective cyclooxygenase-2 inhibitors on alkaline secretory and mucosal ulcerogenic responses in rat duodenum. Life Sci. 61: 1603-1611
65. Hubbard, R. C., Mehlisch, D. R., Jasper, D. R., Nugent, M. J., Yu, S., Isakson, P. C. (1996) SC 58635, a highly selective inhibitor of COX-2 is an effective analgesic in an acute post surgical pain model. J. Invest. Med. 44: 293A
66. Jouzeau, J.Y., Terlain, B., Abid, A., Nedelec, E., Netter, P. (1997) Cyclooxygenase isoenzymes. How recent findings affect thinking about nonsteroidal anti-inflammatory drugs. Drugs 53: 563-582
67. Kapoor, A., Majumdar, D. K., Yadav, M. R. (1998) Crystal forms of nimesulide - a sulfonanilide (NSAID). Indian J. Chem. 37B: 572-575
68. Kargman, S., Charleson, S., Cartwright, M., Frank, J., Riendeau, D., Mancini, J., Evans, J., O'Neill, G. (1996) Characterization of prostaglandin G/H synthase 1 and 2 in rat, dog, monkey and human gastrointestinal tracts. Gastroenterology 111: 445-454
69. Kawamori, T., Rao, C. V., Seibert, K., Reddy, B. S. (1998) Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor against colon carcinogenesis. Cancer Res. 58: 409-412
70. Lakshmi, C. S. R., Reddy, M. N., Naidu, P. Y. (1998) Fluorimetric determination of nimesulide with N-(1-naphthyl) ethylene diamine. Indian Drugs 35: 519-520
71. Lanza, F. L., Rack, M. F., Callison, D. A., Hubbard, R. S., Yu, S., Talwalker, S. (1997a) A pilot endoscopie study of the gastroduodenal effects of SC 58635, a novel COX-2 selective inhibitor. Gastroenterology 112: A194 (Abstract)
72. Lanza, F. L., Simon, T., Quan, H., Bolognese, J., Rack, M. F. (1997b) Selective inhibition of cyclooxygenase-2 (COX-2) with MK 0966 (250 mg qd) is associated with less gastrointestinal damage than aspirin (ASA) 650 mg qid or ibuprofen (IBU) 800 mg tid. Gastroenterology 112: A194 (Abstract)
73. Laudanno, O. M., Cesolari, J. A., Esnarriaga, J., Flaherty, P., Vada, J., Guastalli, G., Miguel, P. S., Bedini, O. A. (1998) In-vivo selectivity of nonsteroidal anti-inflammatory drugs on COX1-COX2 and gastrointestinal ulcers, in rats. Acta Gastroenterol. Latinoam. 28: 249-255
74. Lecomte, J., Buyse, H., Taymans, J., Monti, T. (1994) Treatment of tendinitis and bursitis: a comparison of nimesulide and naproxen sodium in a double-blind parallel trial. Eur. J. Rheumatol. Inflamm. 14: 29-32
75. Lim, H., Paria, B. C., Das, S. K. (1997) Multiple female reproductive failures in cyclooxygenase-2 deficient mice. Cell 91: 197-208
76. Lipsky, P. E. (1999a) Specific COX-2 inhibitors in arthritis, oncology and beyond: which way is the science headed? J. Rheumatol. 26: 25-30
77. Lipsky, P. E. (1999b) The clinical potential of cyclooxygenase-2 specific inhibitors. Am. J. Med. 106: 51S-57S
78. Litchfield, J. T., Wilcoxan, J. (1949) A simplified method for evaluating dose-effect experiments. J. Pharmacol. Exp. Therap. 96: 99-113
79. Lucker, P. W. (1991) Report on the Pharmacokinetics and relative bioavailability/bioequivalence of three different nimesulide formulations in 18 healthy volunteers. Helsinn data on file. TSD 5336
80. Lucker, P. W. (1992) Bioavailability after single administration to 18 subjects of the tablets or granules. Influence of food. Helsinn data on file. TSD 556SE
81. Lucker, P. W., Pawlowski, C., Friedrich, I., Faiella, F., Magni, E. (1994) Double blind randomised, multicentre clinical study evaluating the efficacy and tolerability of nimesulide in comparison with etodolac in patients suffering from osteo-arthritis of the knee. Eur. J. Rheumatol. Inflamm. 14: 29-38
82. Magni, E. (1991) Nimesulide: an overview. Drug Invest. 3 (Suppl 2): 1-3
83. Malofiejew, M., Blaszkiewicz, Z. (1979) Influence of R 805 on the contractility and reactivity of rat myometrium. Arch. Int. Pharmacodyn. 238: 233-243
84. Mandell, B. F. (1999) COX-2 selective NSAIDs: biology, promises and concerns. Clevel. Clinic J. Med. 66: 285-292
85. Marbet, G. A., Yasikoff-Strub, M. L., Macciocchi, A., Tsakiris, D. A. (1998) The effect of nimesulide versus placebo on hemostasis in healthy volunteers. Eur. J. Clin. Pharmacol. 54: 383-387
86. Melis, G. B., Paoletti, A. M., Mais, V., Ajossa, S., Guerriero, S. (1997) Controlled clinical study of the efficacy and tolerability of methoxybutropate compared to nimesulide in gynecology. Minerva Ginecol. 49: 409-415
87. Miller, T. A. (1983) Protective effects of prostaglandins against gastric mucosal damage. Am. J. Physiol. 245: G601-G623
88. Moore, G. G. I., Harrington, J. K. (1974) U.S. patent. 3,840597 Morham, S. G., Langenbach, R., Loftin, C. D., Tiano, H. F., Vouloumano, N., Jenette, J. C. (1995) Prostaglandin synthase 2 gene description causes severe renal pathology in the mouse. Cell 83: 473-482
89. Moore, G. G. I., Harrington, J. K. (1974) U.S. patent. 3,840597 Morham, S. G., Langenbach, R., Loftin, C. D., Tiano, H. F., Vouloumano, N., Jenette, J. C. (1995) Prostaglandin synthase 2 gene description causes severe renal pathology in the mouse. Cell 83: 473-482
90. Nakatsugi, S., Terada, N., Yoshimura, T., Horie, Y., Furukawa, M. (1996a) Effects of nimesulide, a preferential cyclooxygenase-2 inhibitor, on carrageenan-induced pleurisy and stress induced gastric lesions in rats. Prostaglandins Leukot. Essent. Fatty Acids 55: 395-402
91. 2 production by cyclooxygenase-2 from endogenous and exogenous arachidonic acid in rat peritoneal macrophages stimulated with lipopolysaccharide. Prostaglandins Leukot. Essent. Fatty Acids 55: 451-457
92. Nakatsugi, S., Fukutake, M., Takahashi, M., Fukuda, K., Isoi, T., Taniguchi, Y., Sagimura, T., Wakabayashi, K. (1997) Suppression of intestinal polyp development by nimesulide, a selective cyclooxygenase-2 inhibitor in min mice. Jpn. J. Cancer Res. 88: 1117-1120
93. Navar, J. G., Inscho, E. W., Majid, D. S., Imig, J. D., Harrison-Bernard, L. M., Mitchel, K. D. (1996) Paracrine regulation of the renal microcirculation. Physiol. Rev. 76: 425-536
94. Olive, G., Rey, E. (1993) Effect of age and disease on the pharmacokinetics of nimesulide. Drugs 46 (Suppl. 1): 73-78
95. delta716 knockout mice by inhibition of cyclooxygenase-2 (COX-2). Cell 87: 803-809
96. Ottonello, L., Dapino, P., Pastorino, G., Dallegri, F. (1992) Inhibition of the neutrophil oxidative response induced by the oral administration of nimesulide in normal volunteers. J. Clin. Lab. Immunol. 37: 91-96
97. Panara, M. R., Pandovano, R., Sciulli, M. G., Santini, G., Renda, G., Rotondo, M. T., Pace, A., Patrone, C., Patrignani, P. (1998) Effects of nimesulide on constitutive and inducible prostanoid biosynthesis in human beings. Clin. Pharmacol. Ther. 63: 672-681
98. Pandya, K. K., Satia, M. C., Modi, I. A., Modi, R. I., Chakravarthy, B. K., Gandhi, T. P. (1997) High performance thin layer chromatography for the determination of nimesulide in human plasma, and its use in pharmacokinetic studies. J. Pharm. Pharmacol. 49: 773-776
99. Parabita, G.F., Zanetti, U., Scalvini, F., Rossi, D., Scaricabarozzi, I. (1993) A controlled clinical study of the efficacy and tolerability of nimesulide versus naproxen in maxillofacial surgery. Drugs 46 (Suppl. 1): 171-173
100. Pasinetti, G. M., Alsen, P. S. (1998) Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain. Neuroscience 87: 319-324
101. Pasticci, M. B., Menichetti, F., Di Candilo, F. (1990) Nimesulide, thrombocytopenic pupura, and human immunodeficiency virus (HIV) infection. Ann. Intern. Med. 112: 233-234
102. Pastorello, E. A., Zara, C., Riario-Sforza, G. G., Pravettoni, V., Incorvaia, C. (1998) Atopy and intolerance of antimicrobial drugs increase the risk of reactions to acetaminophen and nimesulide in patients allergic to nonsteroidal anti-inflammatory drugs. Allergy 53: 880-884
103. Pelletier, J. P., Mineau, F., Fernandes, J., Kiansa, K., Ranger, P., Martel-Pelletier, J. (1997) Two NSAIDs, nimesulide and naproxen, can reduce the synthesis of urokinase and IL-6 while increasing PAI-1, in human OA synovial fibroblasts. Clin. Exp. Rheumatol. 15: 393-398
104. Perucca, E. (1993) Drug interactions with nimesulide. Drugs 46 (Suppl. 1): 79-82
105. Piel, G., Pirotte, I., Delneuville, I., Neven, P., Llabres, G., Delarge, J., Delattre, L. (1997) Study of the influence of both cyclodextrins and L-lysine on the aqueous solubility of nimesulide; isolation and characterization of nimesulide-L-lysine-cyclodextrin complexes. J. Pharm. Sci. 86: 475-480
106. Pierleoni, P., Tonelli, P., Scaricabarozzi, I. (1993) A double blind comparison of nimesulide and ketoprofen in dental surgery. Drugs 46 (Suppl. 1): 168-170
107. Piraccini, B. M., Fanti, P. A., Morelli, R., Tosti, A. (1994) Hallopeau's acrodermatitis continua of the nail apparatus: a clinical and pathological study of 20 patients. Acta Derm. Venerol. 74: 65-67
108. Pirhonen, J., Pulkkinen, M. (1995) The effect of nimesulide and naproxen on the uterine and ovarian arterial blood flow velocity. A Doppler study. Acta Obstet. Gynecol. Scand. 74: 549-553
109. Pochobradsky, M. G., Mele, G., Beretta, A., Montagnani, G. (1991) Post marketing survey of nimesulide in the short-term treatment of osteoarthrilis. Drugs Exp. Clin. Res. 17: 197-204
110. Quaratino, D., Romano, A., Papa, G., DiFonso, M., Giuffreda, F., D'Ambrosio, F. P., Venuti, A. (1997) Long-term tolerability of nimesulide and acetaminophen in nonsteroidal anti-inflammatory drug intolerant patients. Ann. Allergy Asthma Immunol. 79: 47-50
111. Rabasseda, X. (1996) Nimesulide: a selective cyclooxygenase-2 inhibitor anti-inflammatory drug. Drugs Today 32: 365-384
112. Reddy, B. S., Rao, C. V., Siebert, K. (1996) Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res. 56:4566-4569
113. Reddy, M. N., Reddy, K. S., Shankar, D. G., Sreedhar, K. (1998) Spectrophotometric determination of nimesulide. Indian J. Pharm. Sci. 60: 172-173
114. Riendeau, D., Percival, M. D., Boyce, S., Brideau, C., Charleson, S., Cromlish, W., Ethier, D., Evans, J., Falgueyret, P., Fore-Hutchinson, A. W., Gordon, R., Greig, G., Gresser, M. (1997) Biochemical and pharmacological profile of a tetra-substituted furanone as a highly selective COX-2 inhibitor. Br. J. Pharmacol. 121: 105-117
115. Robert, A., Nezamis, J. E., Lancaster, C., Hanchar, A. J. (1979) Cytoprotection by prostaglandins in rats: prevention of gastric necrosis produced by alcohol. HCl, NaOH, hypertonic NaCl and thermal injury. Gastroenterology 77: 433-443
116. Rodriguez, L. A. Z., Cattaruzzi, C., Troncon, M. G., Agostinis, L. (1998) Risk of hospitalisation for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists and other antihypertensive drugs. Arch. Intern. Med. 158: 33-39
117. Rosales, C. L., Cisneros-Lugo, J. H., Enciso, L. J. R., Sandoval, M. G. G. (1989) Nimesulide in the treatment of primary dysmenorrhea. Comparative clinical evaluation with mefenamic acid and fentiazac. Ginecol. Obstet. Mex. 57: 196-201
118. Rufer, C., Schillinger, E., Bottcher, I., Repenthin, W., Herrmann, C. (1982) Nonsteroidal anti-inflammatories-XII. Mode of action of anti-inflammatory methane sulfonanilides. Biochem. Pharmacol. 31: 3591-3596
119. Sarkar, P., McIntosh, J. M., Leavitt, R., Gauthro, H. (1997) A unique metabolite of nimesulide. J. Anal. Toxicol. 21: 197-202
120. Sawdy, R., Slater, D., Fisk, N., Edmonds, D. K., Bennett, P. (1997) Use of a cyclooxygenase type 2 selective nonsteroidal anti-inflammatory agent to prevent preterm delivery. Lancet 350: 265-266
121. ++ channel current in myometrial smooth muscle from pregnant women. Br. J. Pharmacol. 125: 1212-1217
122. Schmassmann, A., Peskar, B. M., Stettler, C., Netzer. P., Stroff, T., Flogerzi, B., Halter, F. (1998) Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastrointestinal ulcers in rats. Br. J. Pharmacol. 123: 795-804
123. Sengupta, S., Velpandian, T., Kabir, S. R., Gupta, S. K. (1998) Analgesic efficacy and pharmacokinetics of topical nimesulide gel in healthy human volunteers: double blind comparison with piroxicam, diclofenac and placebo. Eur. J. Clin. Pharmacol. 54: 541-547
124. Senna, G. E., Passalacqua, G. Andri, G., Dama, A. R., Albano, M., Fregonese, L., Andri, L. (1996) Nimesulide in the treatment of patients intolerant of aspirin and other NSAIDs. Drug Safety 14: 94-103
125. Singh, S., Sharda, N., Mahajan, L. (1999) Spectrophotometric determination of pKa of nimesulide. Int. J. Pharm. 176: 261-264
126. Spaziani, E. P., Lantz, M. E., Benolt, R. R., O'Brien, W. F. (1996) The induction of cyclooxygenase-2 (COX-2) in intact human amnion tissue by interleukin 4. Prostaglandins 51: 215-223
127. Steenbergen, W. V., Peeters, P., De Bondt, J., Staessen, D., Buscher, H., Laporta, T., Roskams, T., Desmet, V. (1998) Nimesulide induced acute hepatitis: evidence from six cases. J. Hepatol. 29: 135-141
128. Steinhauslin, F., Munafo, A., Buclin, T., Macciocchi, A., Biollaz, T. (1993) Renal effects of nimesulide in furosemide treated subjects. Drugs 46 (Suppl. 1): 257-262
129. Stewart, W. F., Kawas, C., Corrada, M., Metter, E. J. (1997) Risk of Alzheimer's disease and duration of NSAID use. Neurology 48: 626-632
130. Swingle, K. F., Moore, G. G. I., Grant, T. J. (1976) 4-Nitro-2-phenoxymethanesulfonanilide (R 805): a chemically novel anti-inflammatory agent. Arch. Int. Pharmacodyn. 221: 132-139
131. Takahashi, M., Fukutake, M., Yokota, S. (1996) Suppression of azoxymethane induced aberrant crypt foci in rat colon by nimesulide, a selective inhibitor of cyclooxygenase-2. J. Cancer Res. Clin. Oncol. 122: 219-222
132. Taniguchi, Y., Deguchi, Y., Noda, K. (1996) Interaction between enoxicam, a new antimicrobial and nimesulide a new nonsteroidal anti-inflammatory agent in mice. Inflamm. Res. 45: 376-379
133. Taniguchi, Y., Yokoyama, K., Inui, K., Deguchi, Y., Furukawa, K., Noda, K. (1997) Inhibition of brain cyclooxygenase-2 activity and the antipyretic action of nimesulide. Eur. J. Pharmacol. 330: 221-229
134. Tognella, S. (1993) Nimesulide, new clinical opportunities. Drugs 46 (Suppl. 1): 275-276
135. Tool, A. T., Verhoeven, A. J. (1995) Inhibition of the production of platelet activating factor and leukotriene B4 in activated neutrophils by nimesulide due to an elevation of intracellular cyclic adenosine monophosphate. Arzneim. Forsch. 45: 1110-1114
136. 4 by human eosinophils. Eur. Respir. J. Suppl. 22: 141s-145s
137. Ugazio, A. G., Guarnaccia, S., Berardi, M., Renzetti, I. (1993) Clinical and pharmacokinetic study of nimesulide in children. Drugs 46 (Suppl. 1): 215-218
138. Vago, T., Bevilacqua, M., Norbiato, G. (1995) Effect of nimesulide action time dependence on selectivity towards prostaglandin G/H synthase/cyclooxygenase activity. Arzneim. Forsch. 45: 1096-1098
139. Vane, J. R., Botting, R. M. (1996) Overview: mechanism of action of anti-inflammatory drugs. In: Vane, J. R., Botting, J., Botting, R. (eds) Improved Nonsteroidal Anti-inflammatory Drugs. Cox-2 Enzyme Inhibitors. Kluwer Academic Publishers/William Harvey Press, London, pp 1-27
140. Vane, J. R., Botting, R. M. (1998) Anti-inflammatory drugs and their mechanism of action. Inflamm. Res. 47: S78-S87
141. Vavia, P. R., Adhage, N. A. (1999) Inclusion complexation of nimesulide with β-cyclodextrins. Drug Dev. Ind. Pharm. 25: 543-545
142. Wallace, J. L. (1992) Prostaglandins, NSAIDs and cytoprotection. Gastrointest. Pharmacol. 21: 631-641
143. Wallace, J. L., Reuter, B. K., McKnight, W., Bak, A. (1998) Selective inhibitors of cyclooxygenase-2: are they really effective, selective and GI safe? 27: S28-S34
144. Ward, A., Brogden, R. N. (1988) Nimesulide, a preliminary review of its pharmacological properties and therapeutic efficacy in inflammation states. Drugs 36: 732-753
145. Warrington, S. J., Ravic, M., Dawnay, A. (1993) Renal and general tolerability of repeated doses of nimesulide in normal subjects. Drugs 46 (Suppl. 1): 263-269
146. Whittle, B. J. R. (1976) Relationship between the prevention of rat gastric erosions and the inhibition of acid secretion by prostaglandins. Eur. J. Pharmacol. 40: 233-239
147. Wober, W., Rahlfs, V. W., Buchl, N., Grassle, A., Macciocchi, A. (1998) Comparative efficacy and safety of the nonsteroidal anti-inflammatory drugs nimesulide and diclofenac in patients with acute subdeltoid bursitis and bicipital tendinitis. Int. J. Clin. Pract. 52: 169-175
148. Wu, W. X., Unno, N., Ma, X. H., Nathanielsz, P. W. (1998) Inhibition of prostaglandin production by nimesulide is accompanied by changes in expression of the cassette of uterine labor-related genes in pregnant sheep. Endocrinology 139: 3096-3103
149. Yan, S. D., Zhu, H., Fu, J., Yan, S. F., Roher, A., Tourtellotte, W. W. (1997) Amyloid-β peptide receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease. Proc. Natl Acad. Sci. USA 94: 5296-5301
150. 2 production. Inflamm. Res. 45: 246-253